A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9
Open Access
- 18 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10916
Abstract
Prostate cancer (PCa) is a common malignant cancer of the urinary system. Drug therapy, chemotherapy, and radical prostatectomy are the primary treatment methods, but drug resistance and postoperative recurrence often occur. Therefore, seeking novel anti-tumor compounds with high efficiency and low toxicity from natural products can produce a new tumor treatment method. Matijin-Su [N-(N-benzoyl-L-phenylalanyl)-O-acetyl-L-phenylalanol, MTS] is a phenylalanine dipeptide monomer compound that is isolated from the Chinese ethnic medicine Matijin (Dichondra repens Forst.). Its derivatives exhibit various pharmacological activities, especially anti-tumor. Among them, the novel MTS derivative HXL131 has a significant inhibitory effect against prostate tumor growth and metastasis. This study is designed to investigate the effects of HXL131 on the growth and metastasis of human PCa cell lines PC3 and its molecular mechanism through in vitro experiments combined with proteomics, molecular docking, and gene silencing. The in vitro results showed that HXL131 concentration dependently inhibited PC3 cell proliferation, induced apoptosis, arrested cell cycle at the G2/M phase, and inhibited cell migration capacity. A proteomic analysis and a Western blot showed that HXL131 up-regulated the expression of proliferation, apoptosis, cell cycle, and migration-related proteins CYR61, TIMP1, SOD2, IL6, SERPINE2, DUSP1, TNFSF9, OSMR, TNFRSF10D, and TNFRSF12A. Molecular docking, a cellular thermal shift assay (CETSA), and gene silencing showed that HXL131 had a strong binding affinity with DUSP1 and TNFSF9, which are important target genes for inhibiting the growth and metastasis of PC3 cells. This study demonstrates that HXL131 exhibited excellent anti-prostate cancer activity and inhibited the growth and metastasis of prostate cancer cells by regulating the expression of DUSP1 and TNFSF9.Keywords
Funding Information
- Science and Technology Planning Project of Guizhou Province (QKHZC[2022]194)
- main projects of the Natural Science Foundation of Guizhou province (QKHJC-ZK[2022]ZD031)
- Guizhou province “Hundred” level innovative talent training project (QKHPTRC-GCC[2022]034-1)
This publication has 59 references indexed in Scilit:
- Synthesis and anti-tumor activity evaluation of Matijin-Su derivativesBioorganic Chemistry, 2014
- Dual specificity phosphatase 1 expression inversely correlates with NF‐κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanismMolecular Oncology, 2013
- Snail promotes Cyr61 secretion to prime collective cell migration and form invasive tumor nests in squamous cell carcinomaCancer Letters, 2013
- Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agentsBioorganic & Medicinal Chemistry, 2011
- Matrix Metalloproteinase-9 Regulates Tumor Cell Invasion through Cleavage of Protease Nexin-1Cancer Research, 2010
- The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasisCell Research, 2010
- Synthesis and anti-hepatitis B virus activities of Matijing-Su derivativesBioorganic & Medicinal Chemistry, 2009
- Early versus delayed endocrine therapy for prostate cancerEndocrine-Related Cancer, 2007
- Cyr61 Suppresses Growth of Human Endometrial Cancer CellsJournal of Biological Chemistry, 2004
- RETRACTED ARTICLE: Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β-catenin–c-myc–p53 pathwayOncogene, 2004